Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Perimeter Medical Imaging AI ( (TSE:PINK) ) is now available.
Perimeter Medical Imaging AI reported record revenue for the first quarter of 2025, driven by significant commercial traction of its FDA-cleared Perimeter S-Series device. The company achieved several commercial milestones, including increased case volumes and substantial billings. Additionally, Perimeter is advancing its next-generation Perimeter B-Series device, which incorporates AI technology, and has submitted a Premarket Approval application to the FDA. The pivotal trial results for the B-Series, presented at the American Society of Breast Surgeons meeting, showed promising outcomes, potentially transforming surgical practices by improving intraoperative decision-making and reducing re-excisions.
The most recent analyst rating on (TSE:PINK) stock is a Buy with a C$3.00 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on TSE:PINK Stock
According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.
Perimeter Medical Imaging AI is positioned in a growth phase with strong revenue increases and promising clinical advancements towards FDA approval. However, persistent net losses, cash flow constraints, and bearish technical indicators pose significant challenges. The valuation remains unattractive, but recent strategic corporate events offer potential for future expansion.
To see Spark’s full report on TSE:PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a commercial-stage medical technology company specializing in advanced imaging solutions. The company focuses on developing optical coherence tomography (OCT) devices, such as the Perimeter S-Series and the upcoming Perimeter B-Series, to enhance surgical outcomes, particularly in breast-conserving surgeries.
Average Trading Volume: 47,756
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$34.07M
For detailed information about PINK stock, go to TipRanks’ Stock Analysis page.